Email Alert RSS
Volume 13 Issue 4
Jul.  2022
Turn off MathJax
Article Contents
Abstract
References
Related Articles
KONG Linghua, XIAO Xiaoping, WAN Ru, XIANG Yang. Clinical Application of ThinPrep Imaging System in Cervical Cytology[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(4): 613-619. DOI: 10.12290/xhyxzz.2022-0221
Citation: KONG Linghua, XIAO Xiaoping, WAN Ru, XIANG Yang. Clinical Application of ThinPrep Imaging System in Cervical Cytology[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(4): 613-619. DOI: 10.12290/xhyxzz.2022-0221
shu

Clinical Application of ThinPrep Imaging System in Cervical Cytology

  • Department of Obstetrics and Gynecology, National Clinical Research Center for Obstetric & Gynecologic Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China

Funds: 

Capital's Funds for Health Improvement and Research 2022-1-4011

More Information
  • Corresponding author:

    XIANG Yang, E-mail: xiangy@pumch.cn

  • Received Date: April 19, 2022
  • Accepted Date: May 30, 2022
  • Available Online: June 20, 2022
  • Issue Publish Date: July 29, 2022
    Graphical Abstract
    • Abstract
  •   Objective  To investigate the effectiveness of clinical application of ThinPrep Imaging System (TIS) in cervical cytology.
      Methods  Manual screening results of cervical liquid-based cytology (LBC) specimens from December 2016 to May 2017 and TIS-assisted screening results of LBC specimens from December 2017 to May 2018 in the Obstetrics and Gynecology Outpatient Clinic of Peking Union Medical College Hospital were retrospectively analyzed. The diagnostic rates of abnormal cytology, histological follow-up results for abnormal cytology and high risk-human papillomavirus (Hr-HPV) positivity for abnormal cytology specimens were analyzed and compared between the two screening methods.
      Results  A total of 17 407 manual screening results of cervical LBC specimens and 16 564 TIS-assisted screening results of LBC specimens were included. The overall abnormal cytology diagnostic rate was significantly higher in TIS-assisted screening than in manual screening (15.21% vs. 9.58%, P < 0.001), with the diagnostic rate of atypical squamous cells, atypical squamous cells without excluding high-grade squamous intraepithelial lesion, low-grade squamous intraepithelial lesion, high-grade squamous intraepithelial lesion, atypical glandular cells and adenocarcinoma increasing 2.77%, 0.28%, 2.08%, 0.35%, 0.08% and 0.08%, respectively. All results were statistically different (all P < 0.05). In biopsy follow-up of the patients with abnormal cytology, the histological coincidence rates of TIS-assisted screening were higher than those of manual screening, but the differences were not statistically significant (all P > 0.05). The number of abnormal glandular cells diagnosed by TIS-assisted screening was 1.89 times that of manual screening (53 cases vs. 28 cases), and the number of adenocarcinomas (confirmed by histology) in TIS-assisted screening was 2.3 times as many as that in manual screening (37 cases vs. 16 cases). The Hr-HPV positivity rates of patients with abnormal squamous epithelial cells in TIS-assisted screening and manual screening were not statistically different. Meanwhile, TIS-assisted screening was more time efficient, with 33%-50% reduction of time.
      Conclusion  The use of TIS-assisted screening not only improved the detection rate of abnormal cytology and the work efficiency, but also increased histological compliance rate, which is worthy of further clinical application.
    • FullText(HTML)
    • References (15)
  • [1]
    Hou X, Shen G, Zhou L, et al. Artificial Intelligence in Cervical Cancer Screening and Diagnosis[J]. Front Oncol, 2022, 12: 851367. DOI: 10.3389/fonc.2022.851367
    [2]
    Bao H, Sun X, Zhang Y, et al. The artificial intelligence-assisted cytology diagnostic system in large-scale cervical cancer screening: A population-based cohort study of 0.7 million women[J]. Cancer Med, 2020, 9: 6896-6906. DOI: 10.1002/cam4.3296
    [3]
    Hussain E, Mahanta LB, Borah H, et al. Liquid based-cytology Pap smear dataset for automated multi-class diagnosis of pre-cancerous and cervical cancer lesions[J]. Data Brief, 2020, 30: 105589. DOI: 10.1016/j.dib.2020.105589
    [4]
    Bao H, Bi H, Zhang X, et al. Artificial intelligence-assisted cytology for detection of cervical intraepithelial neoplasia or invasive cancer: A multicenter, clinical-based, observa-tional study[J]. Gynecol Oncol, 2020, 159: 171-178.
    [5]
    Wilbur DC, Nayar R. Bethesda 2014: improving on a paradigm shift[J]. Cytopathology, 2015, 26: 339-342. DOI: 10.1111/cyt.12300
    [6]
    Heider A, Austin RM, Zhao C. HPV test results stratify risk for histopathologic follow-up findings of high-grade cervical intra-epithelial neoplasia in women with low-grade squamous intra-epithelial lesion Pap results[J]. Acta Cytol, 2011, 55: 48-53. DOI: 10.1159/000320877
    [7]
    Levi AW, Harigopal M, Hui P, et al. Use of high-risk human papillomavirus testing in patients with low-grade squamous intraepithelial lesions[J]. Cancer Cytopathol, 2011, 119: 228-234. DOI: 10.1002/cncy.20172
    [8]
    Thrall MJ, Smith DA, Mody DR. Women > or=30 years of age with low grade squamous intraepithelial lesion (LSIL) have low positivity rates when cotested for high-risk human papillomavirus: should we reconsider HPV triage for LSIL in older women?[J]. Diagn Cytopathol, 2010, 38: 407-412. DOI: 10.1002/dc.21209
    [9]
    Özcan Z, Kimiloğlu E, Iğdem AA, et al. Comparison of the Diagnostic Utility of Manual Screening and the ThinPrep Imaging System in Liquid-Based Cervical Cytology[J]. Turk Patoloji Derg, 2020, 36: 135-141.
    [10]
    Wright TC Jr, Stoler MH, Parvu V, et al. Risk detection for high-grade cervical disease using Onclarity HPV extended genotyping in women, >/=21years of age, with ASC-US or LSIL cytology[J]. Gynecol Oncol, 2019, 154: 360-367. DOI: 10.1016/j.ygyno.2019.05.012
    [11]
    Eversole GM, Moriarty AT, Schwartz MR, et al. Practices of participants in the college of american pathologists interlaboratory comparison program in cervicovaginal cytology, 2006[J]. Arch Pathol Lab Med, 2010, 134: 331-335. DOI: 10.5858/134.3.331
    [12]
    Harbhajanka A, Chahar S, Michael CW. The pathological outcome of ThinPrep Pap tests diagnosed as glandular cell abnormalities alone versus combined glandular and squamous abnormalities[J]. Diagn Cytopathol, 2019, 47: 88-93. DOI: 10.1002/dc.24024
    [13]
    Zheng B, Austin RM, Liang X, et al. Bethesda System reporting rates for conventional Papanicolaou tests and liquid-based cytology in a large Chinese, College of American Pathologists-certified independent medical laboratory: analysis of 1394389 Papanicolaou test reports[J]. Arch Pathol Lab Med, 2015, 139: 373-377. DOI: 10.5858/arpa.2014-0070-OA
    [14]
    Amaral RG, Zeferino LC, Hardy E, et al. Quality assurance in cervical smears: 100% rapid rescreening vs. 10% random rescreening[J]. Acta Cytol, 2005, 49: 244-248. DOI: 10.1159/000326144
    [15]
    Tavares SB, de Souza NL, Manrique EJ, et al. Internal quality control for cervical cytopathology: comparison of potential false-negatives detected at rapid prescreening and at 100% rapid review[J]. Acta Cytol, 2014, 58: 439-445. DOI: 10.1159/000368041
    • Related Articles

  • Related Articles

    [1]Society of Gynecologic Oncology, Chinese Medical Association, Branch of Colposcopy and Cervical Pathology, China Healthy Birth Science Association, Professional Committee on Cancer Prevention and Control, Chinese Preventive Medicine Association, Specialized Committee on Cervical Cancer Prevention and Control Research, China Maternal and Child Health Research Association, National Collaborative Group for Cervical Cancer Prevention and Treatment, China Cancer Foundation, Committee on Cervical Cancer, China Anti-Cancer Association, Branch of Obstetric and Gynecological Health Medicine, China International Exchange and Promotive Association for Medical and Health Care. Preventive Human Papilloma Virus Vaccine Guidelines for Clinical Use in China(2025 edition)[J]. Medical Journal of Peking Union Medical College Hospital, 2025, 16(2): 350-360. DOI: 10.12290/xhyxzz.2025-0246
    [2]YIXI Jinba, WANG Gaoxue, BASANG Ciren, GASONG Zhuoga, PU Zhi, CIREN Yangjin, BIAN Zhen, LIU Zhijuan, DU Juan. HPV Survey and Analysis of Women in Xizang[J]. Medical Journal of Peking Union Medical College Hospital. DOI: 10.12290/xhyxzz.2024-0914
    [3]CHEN Yuqing, LI Jinming. Virological Characteristics of the Omicron Variant: Key Mutations, Pathogenicity, and Immune Escape[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(5): 945-952. DOI: 10.12290/xhyxzz.2023-0139
    [4]WANG Xiaodan, ZHANG Zhan, LIU Zhaohui. Analysis of Influencing Factors for High-risk Human Papillomavirus Infection[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(1): 153-158. DOI: 10.12290/xhyxzz.2022-0193
    [5]LIANG Li. Interpretation on The Consensus Among Chinese Experts About Acquisition and Quality Control of Digital Pathological Images in Cervical Liquid Based Cytology[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(4): 571-573. DOI: 10.12290/xhyxzz.2022-0100
    [6]LIU Yanting, ZHANG Lu, CHEN Miao, ZHANG Yan, WEI Chong, PAN Boju, ZHAO Jiawei. A Case of Small B-cell Lymphocytic Lymphoma Diagnosed One Year after Evans Syndrome[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(3): 423-426. DOI: 10.12290/xhyxzz.20200063
    [7]Gynecological Oncology Society of Chinese Medical Association, Chinese Society for Colposcopy and Cervical Pathology. Chinese Expert Consensus on Clinical Application of Human Papilloma Virus Vaccine[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(2): 189-201. DOI: 10.12290/xhyxzz.2021-0082
    [8]Dong XU, Feng-chun ZHANG. Systemic Lupus Erythematosus, Human Papilloma Virus Infection and Vaccine[J]. Medical Journal of Peking Union Medical College Hospital, 2020, 11(3): 252-257. DOI: 10.3969/j.issn.1674-9081.20200042
    [9]Hong-zhi GUAN, Lin CHEN, Zhi-yong LIANG, Ding-rong ZHONG, Jian LI, Wei CUI, Min QIAN, Hai-tao REN, Qing LING, Xuan WANG, Yan-huan ZHAO, Yu-pu GUO. Role of Cerebrospinal Fluid Cytology in Diagnosis of Primary Central Nervous System Lymphoma[J]. Medical Journal of Peking Union Medical College Hospital, 2012, 3(3): 273-278. DOI: 10.3969/j.issn.1674-9081.2012.03.006
    [10]Lu-lu SUN, Dong-yan CAO, Jia-xin YANG, Mei-lu BIAN, Li-hui WEI, Li YANG, Ning-hai CHENG, Yi YANG, You-fang WANG, Xue-mei CHENG, Li-jun HU, Jie CHEN, Jing-he LANG, Keng SHEN. Value-based Medicine of Loop Electrosurgical Excision Procedure and CO2 Laser Vaporization for Cervical Intraepithelial Neoplasia 2[J]. Medical Journal of Peking Union Medical College Hospital, 2011, 2(2): 129-133. DOI: 10.3969/j.issn.1674-9081.2011.02.008

  • Cited by

    Periodical cited type(0)

    Other cited types(3)

Catalog

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (700) PDF downloads (74) Cited by(3)
    Related
    Links: National Health Commission of the People's Republic of China Chinese Academy of Medical Sciences(CAMS) AMLC Check CNKI Database CNKI Term Online Chinese General Practice
    Address：Room 302,Third Floor,Building 7, No. 1 Shuaifuyuan, Wangfujing, Dongcheng District, Beijing 100730, China
    Tel：010-69154261/4262
    E - mail：medj@pumch.cn mjpumch@126.com
    Copyright of website：Editorial Office of Medical Journal of Peking Union Medical College Hospital

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return
    x Close Forever Close